Experience in diagnosis and treatment of 10 COVID-19 patients with history of thoracotomy
10.3760/cma.j.cn112434-20200307-00105
- VernacularTitle:10例开放性胸部手术史的COVID-19患者的诊疗
- Author:
Qiannan GUO
1
;
Ke MA
;
Jun LI
;
Haihao WANG
Author Information
1. 华中科技大学同济医学院附属同济医院心脏大血管外科，武汉 430030
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2020;36(7):411-414
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the outcomes of coronavirus disease 2019 (COVID-19) patients with history of thoracotomy.Methods:A retrospective analysis of clinical diagnosis, treatment data and outcomes of 10 COVID-19 patients with history of thoracotomy were studied in Tongji Hospital of Wuhan.Results:10 COVID-19 patients with history of thoracotomy were severe or critical cases. The clinical manifestations of all patients were mainly represented in respiratory system, and these patients were all confirmed by chest CT and virus nucleic acid detection. After admission, all patients were given oxygen therapy, antiviral therapy (abidol and Lianhuaqingwen), and antibiotic therapy (Moxifloxacin and / or Cefoperazone Sodium and Sulbactam Sodium). Finally, 3 patients died of respiratory failure and 7 patients were cured and discharged smoothly.Conclusion:COVID-19 patients with a history of thoracotomy are easy to develop progression, and the use of antibiotics might be more active. At present, there is no specific treatment, and the combination of multiple methods may be effective.
